Common use of COMPOUND MASKING Clause in Contracts

COMPOUND MASKING. (a) Upon the identification of Preliminary Compounds and Active Compounds through screening of the NeoMorph Screening Library against a particular Target, NeoGenesis shall mask such Preliminary Compounds and Active Compounds from the NeoMorph Screening Library by removing such Compounds from the compound resource information associated with the NeoMorph Screening Library and shall take all other steps reasonably necessary to ensure that information with regard to such Compounds is not available or accessible to any third party, including third parties for which NeoGenesis is screening the NeoMorph Screening Library against other biological targets. NeoGenesis shall similarly mask any Improved Active Compounds which are discovered pursuant to Section 2.2(a).

Appears in 4 contracts

Samples: Confidential Treatment (Neogenesis Pharmaceuticals Inc), Confidential Treatment (Neogenesis Pharmaceuticals Inc), Agreement (Neogenesis Pharmaceuticals Inc)

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.